Previous close | 374.60 |
Open | 378.76 |
Bid | 371.23 x 1100 |
Ask | 373.49 x 800 |
Day's range | 372.18 - 378.93 |
52-week range | 253.03 - 387.51 |
Volume | |
Avg. volume | 1,987,191 |
Market cap | 233.661B |
Beta (5Y monthly) | 1.20 |
PE ratio (TTM) | 34.47 |
EPS (TTM) | 10.81 |
Earnings date | 21 Mar 2024 |
Forward dividend & yield | 5.16 (1.38%) |
Ex-dividend date | 17 Jan 2024 |
1y target est | 390.01 |
Accenture's (ACN) second-quarter fiscal 2024 revenues and earnings are expected to have declined from the year-ago levels.
Get a deeper insight into the potential performance of Accenture (ACN) for the quarter ended February 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Microsoft, Coca-Cola, Accenture, Applied Materials and Pfizer are included in this Analyst Blog.